Skip to main content

Development of a pharmacy-based HIV PrEP service delivery intervention for Washington, District of Columbia (DC): A study protocol.

Publication ,  Journal Article
Tun, W; Kopeka, M; Conserve, DF; Gomez-Berrospi, J; Janson, S; Johnson, C; Ogunbajo, A; Idika, NJ; Duran, J; Lendino, A; Bekele, B; Tsao, MR ...
Published in: PloS one
January 2024

Pharmacy-based PrEP service delivery models can help address many of the barriers that inhibit the uptake of PrEP. In an increasing number of states, legislation has been passed, or is under consideration, to allow pharmacists to initiate PrEP without a prescription from a physician or other prescriber. However, there is not yet legislation in Washington, DC to allow pharmacy-based PrEP despite its potential to curb new cases of HIV, which disproportionately affect the Black community in the area. The DC Ends HIV Plan has a goal of less than 130 new cases of HIV per year by 2030, which would require that over 13,000 high-risk residents use PrEP. However, in 2021 only 6,724 Washingtonians were taking PrEP. This study seeks to address the absence of critical formative research into the factors that would influence the implementation of pharmacy-based PrEP in Washington DC using the Implementation Mapping (IM) framework. A needs assessment will be conducted through in-depth interviews (IDIs) with pharmacists (n = 6), PrEP providers (n = 6), current PrEP users (n = 6), DC Department of Health officials (n = 2), DC Board of Pharmacy officials (n = 4) and pharmacy-based PrEP experts (n = 4) to provide input on the operational aspects of pharmacy-based PrEP model as a strategy to increase PrEP uptake. Information gathered through this needs assessment will be used to develop standard operating procedures for the introduction of pilot pharmacy-based PrEP into community-based retail pharmacies.

Duke Scholars

Published In

PloS one

DOI

EISSN

1932-6203

ISSN

1932-6203

Publication Date

January 2024

Volume

19

Issue

10

Start / End Page

e0311694

Related Subject Headings

  • Pre-Exposure Prophylaxis
  • Pharmacists
  • Pharmacies
  • Male
  • Humans
  • HIV Infections
  • General Science & Technology
  • Female
  • District of Columbia
  • Community Pharmacy Services
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tun, W., Kopeka, M., Conserve, D. F., Gomez-Berrospi, J., Janson, S., Johnson, C., … Hickson, D. (2024). Development of a pharmacy-based HIV PrEP service delivery intervention for Washington, District of Columbia (DC): A study protocol. PloS One, 19(10), e0311694. https://doi.org/10.1371/journal.pone.0311694
Tun, Waimar, Mamaswatsi Kopeka, Donaldson F. Conserve, Jennifer Gomez-Berrospi, Samuel Janson, Courtney Johnson, Adedotun Ogunbajo, et al. “Development of a pharmacy-based HIV PrEP service delivery intervention for Washington, District of Columbia (DC): A study protocol.PloS One 19, no. 10 (January 2024): e0311694. https://doi.org/10.1371/journal.pone.0311694.
Tun W, Kopeka M, Conserve DF, Gomez-Berrospi J, Janson S, Johnson C, et al. Development of a pharmacy-based HIV PrEP service delivery intervention for Washington, District of Columbia (DC): A study protocol. PloS one. 2024 Jan;19(10):e0311694.
Tun, Waimar, et al. “Development of a pharmacy-based HIV PrEP service delivery intervention for Washington, District of Columbia (DC): A study protocol.PloS One, vol. 19, no. 10, Jan. 2024, p. e0311694. Epmc, doi:10.1371/journal.pone.0311694.
Tun W, Kopeka M, Conserve DF, Gomez-Berrospi J, Janson S, Johnson C, Ogunbajo A, Idika NJ, Duran J, Lendino A, Bekele B, Tsao MR, Nezam S, Dieng A, Koranteng-Yorke N, Martin B, BRIDGE Team, Hickson D. Development of a pharmacy-based HIV PrEP service delivery intervention for Washington, District of Columbia (DC): A study protocol. PloS one. 2024 Jan;19(10):e0311694.

Published In

PloS one

DOI

EISSN

1932-6203

ISSN

1932-6203

Publication Date

January 2024

Volume

19

Issue

10

Start / End Page

e0311694

Related Subject Headings

  • Pre-Exposure Prophylaxis
  • Pharmacists
  • Pharmacies
  • Male
  • Humans
  • HIV Infections
  • General Science & Technology
  • Female
  • District of Columbia
  • Community Pharmacy Services